Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020

Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020

IntroductionNon-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide, with liver fibrosis (LF) being a crucial pathological feature in the progression of NAFLD. Insulin resistance (IR) is believed to play an important role in the pathogenesis of NAFLD and the d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bo Yang, Mingsu Gong, Xiaojie Zhu, Yang Luo, Ruiqiu Li, Hai Meng, Yuhan Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Endocrinology
Subjects:	non-alcoholic fatty liver disease liver fibrosis insulin resistance logistic regression TyG-WHtR
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1514093/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Associations between surrogate insulin resistance indexes and osteoarthritis: NHANES 2003–2016
by: Youmian Lan, et al.
Published: (2025-01-01)

Association between triglyceride glucose index-related indices and kidney stones in adults based on NHANES 2007–2020
by: Ming Liu, et al.
Published: (2025-01-01)

Association of the triglyceride glucose index with obesity indicators and hypertension in American adults based on NHANES 2013 to 2018
by: Pingping Huang, et al.
Published: (2025-01-01)

Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study of NHANES 2017–2020
by: Yuou Ying, et al.
Published: (2025-01-01)

Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals
by: Qian Zhang, et al.
Published: (2025-02-01)

Association between the triglyceride glucose body mass index and asthma: evidence from NHANES 2011–2018
by: Sijia Yu, et al.
Published: (2025-01-01)

Correlation analysis of the triglyceride–glucose index and related parameters in metabolic dysfunction-associated fatty liver disease
by: Xin Yang, et al.
Published: (2025-01-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017–2018
by: Jieming Jian, et al.
Published: (2025-01-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
by: R. M. Kurabekova, et al.
Published: (2020-09-01)

Association of triglyceride-glucose-body mass index with all-cause mortality among individuals with cardiovascular disease: results from NHANES
by: Yiaoran Sun, et al.
Published: (2025-01-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01)

Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
by: Amr Elsayed, et al.
Published: (2024-12-01)

Mechanism of DMOC in Diabetes Mellitus with Liver Fibrosis
by: Zizhi XIAO, et al.
Published: (2019-04-01)

Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017–2020
by: Na Zhu, et al.
Published: (2025-01-01)

Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01)

Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease
by: Yang Wang, et al.
Published: (2024-04-01)

Serological Markers to Assess Liver Fibrosis and Their Roles
by: Beom Kyung Kim
Published: (2024-11-01)

Association between non-insulin-based insulin resistance surrogate makers and Helicobacter pylori infection: a population-based study
by: Jiayu Qiu, et al.
Published: (2025-01-01)

The role of the interleukin family in liver fibrosis
by: Zixin Zhang, et al.
Published: (2025-02-01)

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
by: V. T. Ivashkin, et al.
Published: (2022-12-01)

Advanced Imaging Techniques for Assessing Fat, Iron, and Fibrosis in Chronic Liver Disease
by: Sabarish Narayanasamy, et al.
Published: (2025-01-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01)

Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort
by: Antonio Liguori, et al.
Published: (2025-01-01)

Insulin Resistance Mediates the Association Between Vitamin D and Non-Alcoholic Fatty Liver Disease
by: Caiyan Zou, et al.
Published: (2024-12-01)

Large annotated ultrasound dataset of non-alcoholic fatty liver from Saudi hospitals for analysis and applicationsOpen Science framework or (OSF)
by: Fahad Alshagathrh, et al.
Published: (2025-02-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Protective role of ginsenoside Rg1 in the dynamic progression of liver injury to fibrosis: a preclinical meta-analysis
by: Lijuan Dan, et al.
Published: (2025-01-01)

Gene therapy by hepatocyte growth factor results in regression of experimental liver fibrosis
by: N. A. Dzhoyashvili, et al.
Published: (2010-08-01)

Association between mixed exposure of non-persistent pesticides and liver fibrosis in the general US population: NHANES 2013–2016
by: Shuge Shu, et al.
Published: (2025-01-01)

Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
by: Bin Liang, et al.
Published: (2025-02-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

Investigation of the connection between triglyceride-glucose (TyG) index and the risk of acute kidney injury in septic patients - a retrospective analysis utilizing the MIMIC-IV database
by: Pirun Zhang, et al.
Published: (2025-12-01)

Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography
by: Mi Na Kim
Published: (2024-11-01)

Collagen fibers quantification for liver fibrosis assessment using linear dichroism photoacoustic microscopy
by: Yang Qiu, et al.
Published: (2025-04-01)

Association of the triglyceride glucose index with all cause and CVD mortality in the adults with diabetes aged < 65 years without cardiovascular disease
by: Chang Liu, et al.
Published: (2025-01-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Liver macrophage-derived exosomal miRNA-342-3p promotes liver fibrosis by inhibiting HPCAL1 in stellate cells
by: Wenshuai Li, et al.
Published: (2025-02-01)